Drug approval: product licensing by phone.
Buderi
R
R
D003201:Computers; D006105:Granulomatous Disease, Chronic / Q000628:therapy; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use; D008004:Licensure; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
D011994:Recombinant Proteins; D007371:Interferon-gamma